stock
CORT · CORCEPT THERAPEUTICS INC
What CORCEPT THERAPEUTICS INC reports to the SEC, read from its filings.
Open in the appPrice
The live CORT price and today's change.
Sign in to see thisChart
Thirty days of daily bars, with signal levels drawn on them.
Sign in to see thisSignals
The latest signal group Nakagai's scanner recorded on CORT.
Sign in to see thisOptions positioning
Gamma exposure levels from the options market.
Sign in to see thisTechnicals
Trend, momentum and volatility gauges per timeframe.
Sign in to see thisWhat it is
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Filer (SEC EDGAR)
- EDGAR filing index
- Shares outstanding
- 108,098,397 as of 2026-07-22 (XBRL frame CY2026Q2I)
Key stats
Valuation
- P/E
- Locked
- P/S
- Locked
- P/B
- Locked
- Enterprise value
- Locked
- EV/EBIT
- Locked
- FCF yield
- Locked
Margins
- Gross
- —
- Operating
- 0.8%
- Net
- 6.6%
Returns
- ROE
- 7.8%
- ROA
- 6.2%
Health
- Current ratio
- 2.9x
- Debt/equity
- —
Deep value
- NCAV
- $256.75M
- NCAV per share
- $2.38
- Price/NCAV
- Locked
- NNWC
- -$7.60M
- NNWC per share
- -$0.07
- Price/NNWC
- Locked
Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.
Sign in to see thisDebt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.
Results
| Period end | Revenue | Gross profit | Operating income | Net income | Filing |
|---|---|---|---|---|---|
| 2026-06-30 | $256.15M | — | $41.30M | $42.99M | 10-Q filed 2026-07-29 |
| 2026-03-31 | $164.90M | — | -$49.60M | -$31.76M | 10-Q filed 2026-07-29 Assembled from more than one filing; the filing above is only the newest of them. |
| 2025-12-31 | $202.13M | — | $4.49M | $24.29M | DEF 14A filed 2026-04-17 Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter. Assembled from more than one filing; the filing above is only the newest of them. |
| 2025-09-30 | $207.64M | — | $10.22M | $19.67M | 10-Q filed 2025-11-04 |
| 2025-06-30 | $194.43M | — | $26.68M | $35.15M | 10-Q filed 2026-07-29 |
| 2025-03-31 | $157.21M | — | $3.42M | $20.55M | 10-Q filed 2026-07-29 Assembled from more than one filing; the filing above is only the newest of them. |
| 2024-12-31 | $181.89M | — | $25.26M | $30.75M | DEF 14A filed 2026-04-17 Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter. Assembled from more than one filing; the filing above is only the newest of them. |
| 2024-09-30 | $182.55M | — | $46.60M | $47.21M | 10-Q filed 2025-11-04 |
- Assets
- $888.70M
- Equity
- $705.78M
Balance as of 2026-06-30.
Ten years
| Fiscal year end | Revenue | Operating income | Net income | Free cash flow |
|---|---|---|---|---|
| 2025-12-31 | $761.41M | $44.80M | $99.65M | $141.78M |
| 2024-12-31 | $675.04M | $136.95M | $141.21M | $196.12M |
| 2023-12-31 | $482.38M | $107.28M | $106.14M | $126.54M |
| 2022-12-31 | $401.86M | $112.63M | $101.42M | $119.91M |
| 2021-12-31 | $365.98M | $124.48M | $112.51M | $167.42M |
| 2020-12-31 | $353.87M | $128.20M | $106.01M | $150.73M |
| 2019-12-31 | $306.49M | $111.61M | $94.18M | $135.03M |
| 2018-12-31 | $251.25M | $89.50M | $75.41M | $115.37M |
| 2017-12-31 | $159.20M | $52.85M | $129.12M | $60.52M |
| 2016-12-31 | $81.32M | $10.18M | $8.14M | $18.20M |
Company filings
events
Executive or director change, Regulation FD disclosure
Executive or director changeRegulation FD disclosureSep 238-KResults, Regulation FD disclosure
ResultsRegulation FD disclosureJul 298-KOther event
Other eventJun 178-KOther event
Other eventJun 38-KExecutive or director change, Shareholder vote results
Executive or director changeShareholder vote resultsMay 288-KResults, Regulation FD disclosure
ResultsRegulation FD disclosureApr 308-K
5% owners ()
Renaissance Technologies LLC
Stake update
INGALLS & SNYDER LLC
Stake update
The Vanguard Group
Stake update
Renaissance Technologies LLC
Stake update
Insiders, politicians and funds
Insider trades, last 90 days
Vieira Roberto Wandenkolk
President, Oncology
Sale$967,448Oct 5, 7:58 PM ET
Lyon Joseph Douglas
See Remarks
Sale$1,160,731Oct 5, 7:54 PM ET
Maduck Sean
See Remarks
Sale$2,906,601Oct 5, 7:49 PM ET
Vieira Roberto Wandenkolk
President, Oncology
Sale$29,843Sep 18, 7:53 PM ET
Lyon Joseph Douglas
See Remarks
Sale$1,134,947Sep 16, 4:30 PM ET
Politician trades, last 90 days
No politician trades filed in the last 90 days.
Funds
- Bridgewater Associates
Period Tue 30 Jun 2026
0.0%Added - Point72
Puts · Period Tue 30 Jun 2026
0.0%New - Point72
Calls · Period Tue 30 Jun 2026
0.0%New
News
Stories that named CORT, and the market events around them.
Sign in to see thisBoard
Recent signals
Signals open up here once a member has posted about CORT.
Signals are informational.
Posts · 0
No posts yet.
nakagai
Signals on CORT come from a rule, not a model.
Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.
Members post on the CORT board